Combating Illicit Xylazine Act aims to control xylazine by scheduling it as a controlled substance and regulating its use.
The Combating Illicit Xylazine Act seeks to address the misuse of xylazine by scheduling it as a controlled substance under the Controlled Substances Act. The bill defines xylazine and its derivatives, and it mandates that the United States Sentencing Commission review and amend its guidelines for offenses involving xylazine. It also delays the implementation of certain registration, inventory, and recordkeeping requirements for practitioners and labeling, packaging, and distribution logistics for xylazine.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.